263 related articles for article (PubMed ID: 34026437)
1. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice.
Clemen R; Freund E; Mrochen D; Miebach L; Schmidt A; Rauch BH; Lackmann JW; Martens U; Wende K; Lalk M; Delcea M; Bröker BM; Bekeschus S
Adv Sci (Weinh); 2021 May; 8(10):2003395. PubMed ID: 34026437
[TBL] [Abstract][Full Text] [Related]
2. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
3. Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.
Bose A; Lowe DB; Rao A; Storkus WJ
Melanoma Res; 2012 Jun; 22(3):236-43. PubMed ID: 22504156
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a repertoire of functional untolerized CD4+ T cells specific for melanoma-associated antigens.
Huber V; Benkhoucha M; Huard B
Scand J Immunol; 2011 Jul; 74(1):80-6. PubMed ID: 21375556
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin.
Garulli B; Di Mario G; Sciaraffia E; Kawaoka Y; Castrucci MR
J Biomed Biotechnol; 2011; 2011():497364. PubMed ID: 22007143
[TBL] [Abstract][Full Text] [Related]
6. Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.
Huff AL; Evgin L; Thompson J; Kottke T; Driscoll CB; Tonne J; Wongthida P; Schuelke M; Shim KG; Mer G; Ramirez-Alvarado M; Vile R
Mol Ther; 2020 Dec; 28(12):2540-2552. PubMed ID: 32877695
[TBL] [Abstract][Full Text] [Related]
7. Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell-Driven Inflammation.
Schwenck J; Mehling R; Thaiss WM; Kramer D; Menendez IG; Öz HH; Hartl D; Schulze-Osthoff K; Hailfinger S; Ghoreschi K; Quintanilla-Martinez L; Carlsen H; Röcken M; Pichler BJ; Kneilling M
Mol Imaging Biol; 2020 Jun; 22(3):504-514. PubMed ID: 31482411
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
10. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.
Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL
Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681
[TBL] [Abstract][Full Text] [Related]
11. Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b
Gogesch P; Schülke S; Scheurer S; Mühlebach MD; Waibler Z
Mol Immunol; 2018 Sep; 101():19-28. PubMed ID: 29852456
[TBL] [Abstract][Full Text] [Related]
12. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
[TBL] [Abstract][Full Text] [Related]
13. H
Fan Y; Bai T; Tian Y; Zhou B; Wang Y; Yang L
Drug Des Devel Ther; 2021; 15():209-222. PubMed ID: 33488068
[TBL] [Abstract][Full Text] [Related]
14. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
[TBL] [Abstract][Full Text] [Related]
15. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
Durgan K; Ali M; Warner P; Latchman YE
Cancer Immunol Immunother; 2011 Apr; 60(4):547-58. PubMed ID: 21240487
[TBL] [Abstract][Full Text] [Related]
16. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
[TBL] [Abstract][Full Text] [Related]
18. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
Karan D; Krieg AM; Lubaroff DM
Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
[TBL] [Abstract][Full Text] [Related]
20. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
